Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study-Reference-Cited by-同舟云学术

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Published:2020-11-17 Issue:3 Volume:27 Page:e37-e38
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Attauabi Mohamed¹²³^ORCID,Burisch Johan¹²,Seidelin Jakob Benedict³

Affiliation:

1. Gastrounit, Medical Division, Copenhagen University Hospital, Hvidovre, Denmark

2. Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark

3. Department of Gastroenterology and Hepatology, Herlev Hospital, University of Copenhagen, Denmark

Abstract

This double-center cohort study found a high short-term and long-term efficacy of ustekinumab for perianal fistulizing Crohn disease that was also well tolerated.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/27/3/e37/36275523/izaa297.pdf

Reference5 articles.

1. Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease;Hellers;Gut.,1980

2. Management of internal fistulas in Crohn’s disease;Levy;Gastroenterology.,1991

3. Anal complications in Crohn’s disease;Williams;Dis Colon Rectum.,1981

4. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease;Gecse;Gut.,2014

5. Clinical practice guideline for the medical management of perianal fistulizing Crohn’s disease: the Toronto consensus;Steinhart;Inflamm Bowel Dis.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Ustekinumab for Crohn’s Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan;Crohn's & Colitis 360;2024-04-01

2. Management of Perianal Fistulizing Crohn’s Disease;Inflammatory Bowel Diseases;2023-09-06

3. Crohn’s Disease-Associated and Cryptoglandular Fistulas: Differences and Similarities;Journal of Clinical Medicine;2023-01-06

4. Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease;Frontiers in Medicine;2022-06-15

5. Rates and Predictors of Long-term Clinical Outcomes in Patients With Perianal Crohn’s Disease on Biologic Therapy;Journal of Clinical Gastroenterology;2022-06-10